In a wide-ranging talk with UCLA Health physicians, Wednesday, Oct. 28, United States Surgeon General Jerome Adams, MD, MPH, addressed the politicization of the pandemic and the means of containing the spread of COVID-19. He also offered hope that a vaccine for the virus will be available by year’s end.
A UCLA-led review of nine years of social media posts with the hashtag #BCSM suggests that Twitter can be a useful resource not only for patients, but also for physicians and researchers.
More women could potentially be spared an axillary lymph node dissection — the surgical removal of 10-20 lymph nodes — a procedure that causes disabling arm swelling in up to 25% of women, according to a UCLA study.
Untreated HIV infection is linked with epigenetic changes suggesting rapid aging. A new study by UCLA researchers shows that antiretroviral therapy given over two years was unable to completely restore age-appropriate epigenetic patterns, leaving patients more susceptible to aging-related illnesses.
The outcome of the presidential election will determine our nation’s path forward on numerous health and healthcare fronts. As the nation continues to grapple with COVID-19, systemic racism, climate change and other critical public health issues, there’s much at stake. Join us for an insightful session moderated by Gerald Kominski, professor at the UCLA Fielding School of Public Health professor and senior fellow at FSPH’s UCLA Center for Health Policy Research. The program will feature two health policy experts, Dr. Lanhee Chen of the Hoover Institution of Stanford University and Mark Peterson, professor of public policy, political science and law at UCLA, discussing the Democratic and Republican health platforms, their key policy implications, and how each reflects the party’s vision for the nation’s health. An optional small group networking session will follow the webinar.
UCLA researchers have identified a compound that can reproduce the effect of exercise in muscle cells in mice. The findings are published today in the journal Cell Reports Medicine.
UCLA scientists discovered that astrocytes, a cell type long implicated in brain diseases, is remarkably malleable and shows responses in a mouse model that suggest potential targets for drugs for Huntington’s disease.
Dr. Antoni Ribas, a world-renowned physician–scientist and professor of medicine at the David Geffen School of Medicine at UCLA, has been named to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.
The UCLA Fielding School of Public Health will host the second annual “Healthcare Management Case Competition,” pitting teams of graduate students against each other to solve a real health care challenge presented by UCLA Health, the premier sponsor.
The UCLA Fielding School of Public Health welcomes nine new faculty members, in four different academic departments, in time for the 2020-2021 academic year.
Health care leaders have new, improved tools to identify children at the greatest risk of preventable deaths, based on surveys of more than 67 countries around the world by researchers at the UCLA Fielding School of Public Health.
UCLA researchers have found that a drug that activates the body’s natural defenses by behaving like a virus may also make certain stealthy melanoma tumors visible to the immune system, allowing them to be better targeted by immunotherapy.
A review of 39 randomized clinical trials by scientists from UCLA and their colleagues from other institutions has found that combining the use medication with psychoeducational therapy is more effective at preventing a recurrence of illness in people with bipolar disorder than medication alone.
UCLA scientists and colleagues studying the effects of cognitive behavioral therapy (CBT) discovered an abnormality in the brains of people with obsessive compulsive disorder (OCD) that may also help to predict who is most likely to respond to CBT.
The UCLA Fielding School of Public Health and UC Speaks Up (a public health violence prevention initiative of the University of California) will co-host an event focusing on sexual violence awareness and prevention among college communities.
A UCLA Fielding School of Public Health researcher’s work on two related research projects published in the past month suggests that in both the United States and in Europe, sustained transmission networks of SARS-CoV-2 became established only after separate introductions of the virus that went undetected.
American women living in states with less restrictive reproductive rights policies are less likely to give birth to low-birth weight babies, according to a team led by UCLA Fielding School of Public Health researchers.
Health care leaders from across the United States will speak at an Oct. 14 event focusing on the critical intersection between social justice and health equity, including bridging gaps in the U.S. health care system and focusing on lessons learned from the COVID-19 pandemic response.
The U.S. Food and Drug Administration has granted emergency use authorization for UCLA Health to launch a new method of COVID-19 detection using sequencing technology called SwabSeq. Capable of testing thousands of samples at once, the method returns accurate, individual results in 12 to 24 hours.
A new report suggests that lingering “brain fog” and other neurological symptoms after COVID -19 recovery may be due to post-traumatic stress disorder (PTSD), an effect observed in past human coronavirus outbreaks such as SARS and MERS.
A coalition of 11 academic institutions and their community partners across California has received a $4.1 million grant from the NIH for a statewide community-engaged approach to addressing COVID-19 among populations that have been disproportionately affected by the pandemic.
Antibiotics may be a good choice for some, but not all, patients with appendicitis, according to results from the Comparing Outcomes of Drugs and Appendectomy (CODA) trial.
Researchers have found at least 10 distinct “hotspot” mutations in more than 80% of randomly selected SAR-CoV-2 sequences from six countries, and these genome hotspots – seen as "typos" that can occur as the virus replicates during cellular division – could have a significant impact in the fight against the COVID-19 pandemic.
UCLA researchers have received a $13 million grant from the National Institutes of Health to find new ways to overcome melanoma resistance to some of the most promising targeted therapies and immunotherapies.
The percentage of low- and middle-income families with children that had burdensome out-of-pocket health care costs fell following the 2014 implementation of the health insurance marketplaces and Medicaid expansion provisions of the Affordable Care Act, known widely as Obamacare,
Dr. Keith Vossel, who is known for his discovery that many Alzheimer’s patients experience nighttime seizures that disrupt their sleep, is the new director of the Mary S. Easton Center for Alzheimer’s Disease Research at UCLA.
UCLA researchers and their colleagues from two other institutions have been awarded a $52 million grant from the National Institutes of Health to lead an international study to better understand the cause and effect of schizophrenia in high-risk youth.
To help better understand the impact and outcomes of COVID-19 in people undergoing cancer treatment, UCLA are participating in a NCI study with cancer centers across the country.
UCLA researchers shed light on how interferon-gamma (IFN-y) guides the treatment response in people with advanced melanoma who are treated with one of the leading immunotherapies — immune checkpoint blockade.
UCLA researchers and colleagues who analyzed electronic health records found that there was a significant increase in patients with coughs and acute respiratory failure at UCLA Health hospitals and clinics beginning in late December 2019, suggesting that COVID-19 may have been circulating in the area months before the first definitive cases in the U.S. were identified. This sudden spike in patients with these symptoms, which continued through February 2020, represents an unexpected 50% increase in such cases when compared with the same time period in each of the previous five years.
A new UCLA study shows partially overlapping patterns of brain function in people with anorexia nervosa and those with body dysmorphic disorder, a related psychiatric condition characterized by misperception that particular physical characteristics are defective.
The UCLA Fielding School of Public Health (FSPH) has joined the Planetary Health Alliance (PHA), a consortium of more than 200 universities, research institutes, and government agencies committed to understanding and addressing global environmental change and its health impacts.
To better understand the effect of the COVID-19 pandemic on cannabis and CBD use, the UCLA Cannabis Research Initiative has launched the Cannabis, CBD and COVID Survey.
In response to the escalating health emergency that is already inflicting substantial damage on people in Southern California and around the world, the UCLA Fielding School of Public Health has created the UCLA Center for Healthy Climate Solutions.
UCLA researchers investigate COVID-19-associated deaths in working-age Latinos. Professors David Hayes-Bautista and Paul Hsu, both with the UCLA Fielding School of Public Health, have found that over the past three months, there was a nearly five-fold increase in death rates among working-age Latinos in California.
A team led by Anne Rimoin, UCLA Fielding School of Public Health professor of epidemiology and Director of the UCLA Center for Global and Immigrant Health, has just launched an epidemiologic study to understand occupational exposure to SARS-CoV-2 and other pathogens in high-risk populations, including veterinary medicine and animal care/welfare workers.
A team that includes UCLA Fielding School of Public Health professor James Macinko is moving forward in its study of why Americans buy firearms with the support of a $2 million grant from the National Science Foundation (NSF).
The Simms/Mann-UCLA Center for Integrative Oncology has received a $50,000 grant from Los Angeles-based PHASE ONE Foundation to support psychosocial care for people with cancer, their families and frontline healthcare workers during the COVID-19 pandemic.